OCT 30, 2019 10:20 AM PDT

Advancing Nanocontainers for Drug Delivery

WRITTEN BY: Nouran Amin

Nanocontainers work by delivering drugs to a localized region in the body, many chemotherapeutics work in that matter. The high specificity of this drug delivery method often is advantageous in avoiding unusual and unwanted side-effects. However, there is always room for improvement--"My group wants to understand in as much detail as possible how the container molecules and the active substances arrange and what properties result from this," says chemistry professor Ann-Christin Pöppler from Julius-Maximilians-Universität (JMU) Würzburg in Bavaria, Germany.

As the loading with curcumin (yellow) increases, the dissolution rate of the containers made of polymeric micelles (blue) decreases. (Image: Ann-Christin Pöppler / Universität Würzburg)

The latest research regarding advancing drug delivery includes a chain of molecules known as polymeric micelles that assemble into spherical structures. "Little is known about the molecular origin of the properties of these structures," says Pöppler. They are already on the market as drug containers and have been used in cosmetics and cancer therapy. The micelles work when they touch fat-soluble products causing them to form a "water-loving" outer shell and a "fat-loving" core.

Learn more about micelles:

Findings were published in the scientific journal Angewandte Chemie which describe the polymeric micelles used in the study. The micelles were derived from substance classes poly(2-oxazoline)s and poly(2-oxazine)s. One of the active substances was taken from the Curcumin spice plant as it is easy to spectroscopically visualize.

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUN 18, 2020
Drug Discovery & Development
FDA Cancels Emergency Approval for Hydroxychloroquine
JUN 18, 2020
FDA Cancels Emergency Approval for Hydroxychloroquine
The US Food and Drug Administration (FDA) has decided to cancel emergency use authorization for Hydroxychloroquine and C ...
JUN 18, 2020
Drug Discovery & Development
Gilead to Trial COVID-19 Drug on Children
JUN 18, 2020
Gilead to Trial COVID-19 Drug on Children
Following the emergency use authorization given to Remdesivir on May 1, Gilead Sciences has announced that it will condu ...
JUN 25, 2020
Drug Discovery & Development
Three New Molecular Targets for Epilepsy
JUN 25, 2020
Three New Molecular Targets for Epilepsy
A study lead by scientists at FutureNeuro discovered three new drugs hold the potential for targeting epilepsy. These dr ...
JUL 19, 2020
Drug Discovery & Development
Study Finds Turmeric has Antiviral Effects
JUL 19, 2020
Study Finds Turmeric has Antiviral Effects
Researchers from the Wuhan University of Engineering in China have found that curcumin, a natural compound found in turm ...
JUL 26, 2020
Drug Discovery & Development
AI Creates Proteins that Rival Those in Nature
JUL 26, 2020
AI Creates Proteins that Rival Those in Nature
Proteins are crucial for the function of cells in living organisms. Now, researchers have developed a machine leaning-le ...
AUG 11, 2020
Drug Discovery & Development
FDA Approves New Opioid for Short-Term Use
AUG 11, 2020
FDA Approves New Opioid for Short-Term Use
The US Food and Drug Administration has announced the approval of Olinvyk (oliceridine), a new opioid that can help mana ...
Loading Comments...